{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:14:14Z","timestamp":1789139654147,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective\/background:<\/jats:title>\n                    <jats:p>Viral hepatitis, particularly hepatitis B virus (HBV) and hepatitis C virus (HCV), infections and tuberculosis (TB) are a global public health concern. Co-infection with HBV or HCV among TB patients may potentiate the risk of hepatotoxicity induced by anti-TB drugs. Hence, the aim of this study was to identify the prevalence of HBV and HCV among TB patients included in the Duhok National Tuberculosis Program (NTP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Duhok NTP Center is a specialized institution in Duhok City, Iraq, concerned with management and follow-up of TB patients. A cross-sectional study was conducted at the center between June 2015 and May 2016. All documented TB patients were analyzed on the basis of socio-demographic and other characteristics. Thereafter, all patients underwent screening for hepatitis B surface antigen (HBsAg), anti-HCV, and anti-HIV using enzyme-linked immunosorbent assay (ELISA). The results obtained were analyzed by entering the data in binary format into a Microsoft Excel spreadsheet. A p value of &lt;.05 was considered to be statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Two-hundred fourteen documented TB patients were recruited in this study, with 127 (59.3%) males and 87 (40.7%) females. The mean age of the patients was 40.34 years (\u00b120.29). Of the total number of patients, four cases (1.8%) were HBsAg-positive and one case (0.9%) was positive for anti-HCV. The variables significantly associated with HBV were history of surgical dental procedure [odds ratio (OR), 0.04; 95% confidence interval (CI), \u22120.01 to 0.04;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .03], and nationality (OR, 13.67; 95% CI, 0.46\u2013210.85;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = .007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The prevalence of HBV and HCV co-infection among TB patients in this study was low. This may be explained by the low rate of blood transfusion among the patients, the very low prevalence of HIV infections in Kurdistan, the negative history of injection drug use, and adherence to universal infection-control measures, including vaccination for HBV. Both history of dental intervention and belonging to a Syrian population were independent risk factors for HBV\/TB co-infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijmyco.2016.06.019","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T15:05:02Z","timestamp":1469027102000},"page":"313-317","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan"],"prefix":"10.4103","volume":"5","author":[{"given":"Muayad A.","family":"Merza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safer M.","family":"Haji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid Mohialdeen Hasan","family":"Alsharafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivan U.","family":"Muhammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20260911","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"R6-12-20260911","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2011.04.005","article-title":"Risk factors during anti tuberculous treatment and implications of hepatitis virus load","volume":"62","author":"Wan","year":"2011","journal-title":"J. Infect"},{"key":"R9-12-20260911","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10096-004-1272-8","article-title":"High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil","volume":"24","author":"Lal","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"R10-12-20260911","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1099\/jmm.0.47492-0","article-title":"Human immunodeficiency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors","volume":"57","author":"Pando","year":"2008","journal-title":"J. Med. Microbiol"},{"key":"R11-12-20260911","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2007.04.015","article-title":"Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients","volume":"12","author":"Kuniholm","year":"2008","journal-title":"Int. J. Infect. Dis"},{"key":"R12-12-20260911","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2458-8-245","article-title":"Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand","volume":"8","author":"Sirinak","year":"2008","journal-title":"BMC Public Health"},{"key":"R13-12-20260911","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.5588\/ijtld.10.0636","article-title":"Hepatitis C virus infection in patients with tuberculosis in Central Brazil","volume":"15","author":"Reis","year":"2011","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"R14-12-20260911","first-page":"396","article-title":"High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia","volume":"10","author":"Richards","year":"2006","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"R15-12-20260911","first-page":"427","article-title":"High prevalence of hepatitis B & C in TB patients \u2013 will it be the next threat to tuberculosis control?","volume":"4","author":"Ul-Haq","year":"2013","journal-title":"JSZMC"},{"key":"R16-12-20260911","first-page":"163","article-title":"Anti-tuberculosis drugs related hepatotoxicity: incidence, risk factors, pattern of changes in liver enzymes and outcome","volume":"17","author":"Khalili","year":"2009","journal-title":"J. Pharm. Sci"},{"key":"R17-12-20260911","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1183\/13993003\/erj.38.Suppl_55.4896","article-title":"Hepatitis C virus infection among tuberculosis patients in Sohag Governorate: seroprevalence and associated risk factors","volume":"38","author":"Badawy","year":"2011","journal-title":"Eur. Respir. J"},{"key":"R18-12-20260911","first-page":"1810","article-title":"Frequency of HBV and HCV among patients undergoing elective surgery in a tertiary care referral hospital in Duhok, Iraqi Kurdistan","volume":"2","author":"Merza","year":"2014","journal-title":"JMSCR"},{"key":"R19-12-20260911","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0970-0218.37698","article-title":"Prevalence of HIV infection among patients of pulmonary tuberculosis attending chest diseases hospital, Jammu (Jammu and Kashmir)","volume":"32","author":"Bahl","year":"2007","journal-title":"Indian J. Community Med"},{"key":"R20-12-20260911","first-page":"370","article-title":"Epidemiology of viral hepatitis B and C in Iraq: a national survey 2005\u20132006, Zanco","volume":"17","author":"Tarky","year":"2013","journal-title":"J. Med. Sci"},{"key":"R21-12-20260911","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/605559","article-title":"Epidemiology of extrapulmonary tuberculosis in the United States, 1993\u20132006","volume":"49","author":"Peto","year":"2009","journal-title":"Clin. Infect. Dis"},{"key":"R22-12-20260911","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1440-1843.2007.01069.x","article-title":"Clinical characteristics of tuberculosis in patients with liver cirrhosis","volume":"12","author":"Cho","year":"2007","journal-title":"Respirology"},{"key":"R23-12-20260911","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5812\/hepatmon.822","article-title":"Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran","volume":"12","author":"Ghadir","year":"2012","journal-title":"Hepat. Mon"},{"key":"R24-12-20260911","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jmv.21603","article-title":"A case-control study of risk factors for hepatitis B virus infection in North Jordan","volume":"82","author":"Hayajneh","year":"2010","journal-title":"J. Med. Virol"},{"key":"R25-12-20260911","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1600-0714.2011.01123.x","article-title":"Oral fluid and hepatitis A, B and C: a literature review","volume":"41","author":"Mahboobi","year":"2012","journal-title":"J. Oral Pathol. Med"},{"key":"R26-12-20260911","first-page":"109","article-title":"Risk factors in chronic hepatitis B infection: a case-control study","volume":"5","author":"Sali","year":"2005","journal-title":"Hepat. Mon"},{"key":"R27-12-20260911","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bpg.2008.11.002","article-title":"Chronic viral hepatitis as a public health issue in theworld","volume":"22","author":"Lavanchy","year":"2008","journal-title":"Best Pract.Res.Clin.Gastroenterol"},{"key":"R28-12-20260911","first-page":"13","article-title":"Epidemiology of hepatitis B in Germany","volume":"12","author":"Radun","year":"2004","journal-title":"Viral Hepat"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2212553116300553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2212553116300553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/01929415-201605030-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:00:33Z","timestamp":1789138833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01929415-201605030-00012"}},"subtitle":["Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?"],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijmyco.2016.06.019","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}